Latest Interesting Articles
(Endovascular Today)
August 19, 2015—Boston Scientific Corporation announced that the company has received US Food and Drug Administration (FDA) approval for the Innova vascular self-expanding stent system to treat peripheral artery disease (PAD) in the superficial femoral artery (SFA) or proximal popliteal artery (PPA). The company has commenced a full commercial launch of the Innova stent system in the United States. The Innova stent system received European CE Mark approval in May 2012.
Read more.
|